METABOLON INC.

Company Overview

Metabolon Inc. was established in 2000 and is headquartered in Morrisville, N.C. Metabolon Inc. is a health technology company providing platforms for diagnostics testing, biomarker discoveries and precision medicines. The company provides its services to various sectors: life science research, pharmaceutical, biotechnology, clinical, consumer and applied markets. The company develops metabolomics, first line phenotyping technology for accessing health. Metabolomics is the study of chemical processes involving metabolites, small molecules, metabolism products and the technology enables understanding of biological systems. The surveying metabolites provide insight into complete phenotype and advanced programs in translational science, treatment mechanism and biomarker identification.

The company offers technology used in various research areas: cancer, metabolics, genomics, immunology, neurology, cardiovascular disease, plants and animal biology. Metabolomics technology is designed for precision medicine, measurement of metabolites, improved influence of gene microbiome, diet, lifestyle and drug treatment. The precision metabolomics technology consists of metabolite library, quality control, proprietary mLIMS system and informatics. Precision metabolomics is an unparalleled technology biomarker technology in diagnostic test development, bioprocess optimization, extracting value from genomics research, disease taxonomy and diagnosis and for tracking drug and nutrient effects. The technology serves precision medicine, pharmaceuticals, biotechnology, nutrition, agriculture, consumer goods and personal care products.

For clinical research validated biomarkers are the basis of new diagnostic tests that enable established precision medicines. The company provides insight for drug toxicity, efficacy of drugs and mechanism of action. The company provides a complete range of metabolomics solutions from the discovery of targeted assays to research. The company provides clinical and consumer applications including meta UDX, meta IMD, quantose IR, quantose IGt and another test. Quantose IR is a laboratory-developed test (LDT), insulin and three non-glycemic biomarkers. It enables the detection of diabetes at early stages.

Company's Business Segments

• Metabolomics  : The company provides metabolomics solutions and services to support life sciences research, diagnostics, and drug development.